Diagnostic Assay Based on hsa-miR-205 Expression Distinguishes Squamous From Nonsquamous Non–Small-Cell Lung CarcinomaDanit Lebanony, Mahesh Mansukhani, Yael Spector et al.|Journal of Clinical Oncology|2009Cited by 410
hsa-miR-191 Is a Candidate Oncogene Target for Hepatocellular Carcinoma TherapyEran Elyakim, Noga Yerushalmi, Einat Sitbon et al.|Cancer Research|2010Cited by 152
Supplementary Figures 1-9, Table 1 from hsa-miR-191 Is a Candidate Oncogene Target for Hepatocellular Carcinoma TherapyEran Elyakim, Noga Yerushalmi, Einat Sitbon et al.|Unknown|2023Cited by 0
Supplementary Figures 1-9, Table 1 from hsa-miR-191 Is a Candidate Oncogene Target for Hepatocellular Carcinoma TherapyEran Elyakim, Noga Yerushalmi, Einat Sitbon et al.|Unknown|2023Cited by 0
Data from hsa-miR-191 Is a Candidate Oncogene Target for Hepatocellular Carcinoma TherapyEran Elyakim, Noga Yerushalmi, Einat Sitbon et al.|Unknown|2023Cited by 0